Search →

Overview

Investing In a Better Future

If you’ve come to this page, we hope you are as excited about Bicycle as we are. Our goal is to be one of the world’s leading solid tumor therapeutics companies. Please give us a call or send us an email if you have questions about our science, clinical programs, strategy or any other aspect of the Bicycle story.

Presentation

05/23/24
May 2024 Corporate Deck
Press
Date
Title
Date
07/22/24
Title
Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024
Date
06/03/24
Title
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Date
05/23/24
Title
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
Date
05/23/24
Title
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
Overview →Stock Information →SEC Filings →Annual General Meeting →UK Annual Reports →Governance + Leadership →Presentation + Events →Analyst Coverage →Press Releases →Investor Resources →

Search